Mesoblast Limited: FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided feedback received from the ...
Science-Based Medicine

RFK Jr. is definitely coming for your vaccines (part 6): Liability, ethics, and policy-based evidence making

As 2026 dawns, look for HHS Secretary Robert F. Kennedy Jr. to ramp up his assault on vaccines using policy-based evidence making and altering Vaccine Court standards.